Department of the Army, DoD.
In accordance with 37 CFR 404.6 and 404.7, announcement is made of the availability for licensing of U.S. Patent Application No. 09/337,946 entitled “Ebola Virion Proteins Expressed from Venezuelan Equine Encephalitis (VEE) Virus Replicons,” filed June 22, 1999. Foreign rights are also available (PCT/US99/14311). The United States Government, as represented by the Secretary of the Army, has rights in this invention.
Commander, U.S. Army Medical Research and Materiel Command, ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, Frederick, MD 21702-5012.Start Further Info
FOR FURTHER INFORMATION CONTACT:
For patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul Mele, Office of Research & Technology Assessment, (301) 619-6664, both at telefax (301) 619-5034.End Further Info End Preamble Start Supplemental Information
Using the Ebola GP, NP, VP24, VP30, VP35 and VP40 virion proteins, a method and composition for use in inducing an immune response which is protective against infection with Ebola virus is described.Start Signature
Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 03-9469 Filed 4-16-03; 8:45 am]
BILLING CODE 3710-08-M